Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Clinical Trial ID NCT00410826

PubWeight™ 4.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00410826

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial. J Clin Oncol 2013 2.29
2 ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. Br J Cancer 2013 0.89
3 The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck. Ann Oncol 2014 0.88
Next 100